← Back to Clinical Trials
Recruiting NCT07542834

NCT07542834 Using Virtual Reality to Improve Medical Training

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07542834
Status Recruiting
Phase
Sponsor Ohio University
Condition Type 2 Diabetes (T2DM)
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2026-04-15
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Cinematic Virtual Reality TrainingTraditional Didactic Lecture

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2026-04-15 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

As the U.S. population ages, future physicians must be prepared to care for older adults with multiple health conditions and complex needs. This study will test whether cinematic virtual reality (VR)-an immersive, interactive learning tool-is more effective than traditional lectures in helping medical students learn about geriatric care. Students who complete the VR training will experience realistic patient scenarios that show what can go wrong in medical care and learn how to apply osteopathic principles to improve outcomes. Researchers will compare students' performance on a clinical skills assessment and explore their experiences with the VR training. The goal is to determine whether cinematic virtual reality can better prepare students for residency and improve their ability to provide compassionate, high-quality care for older adults.

Eligibility Criteria

Inclusion Criteria: able to read and speak English, are age 18 years and older, and are a medical student enrolled at the Ohio University Heritage College of Osteopathic Medicine enrolled in the 2025-2026 academic year. \- Exclusion Criteria: unable to read and speak English, 17 years or younger, and are not a medical student enrolled at the Ohio University Heritage College of Osteopathic Medicine enrolled in the 2025-2026 academic year. \-

Contact & Investigator

Central Contact

Elizabeth A Beverly, PhD

✉ beverle1@ohio.edu

📞 740-593-2524

Principal Investigator

Elizabeth A Beverly, PhD

PRINCIPAL INVESTIGATOR

Ohio University

Frequently Asked Questions

Who can join the NCT07542834 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Type 2 Diabetes (T2DM). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07542834 currently recruiting?

Yes, NCT07542834 is actively recruiting participants. Contact the research team at beverle1@ohio.edu for enrollment information.

Where is the NCT07542834 trial being conducted?

This trial is being conducted at Athens, United States.

Who is sponsoring the NCT07542834 clinical trial?

NCT07542834 is sponsored by Ohio University. The principal investigator is Elizabeth A Beverly, PhD at Ohio University. The trial plans to enroll 100 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology